One study demonstrated that statins increase Foxp3 mRNA transcription and protein production, leading to an increased proportion of Tregs, which may contribute to immune suppression and potentially facilitate melanoma progression.[157] Although both statins and PCSK9 inhibitors are lipid‐lowering agents, their distinct mechanisms of action warrant further investigation. This evidence concerns the gene PCSK9 and melanoma.